These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11042519)

  • 21. Lack of HER-2/neu overexpression in non-Hodgkin's lymphoma.
    Lüftner D; Genvresse I; Geppert R; Kaufmann O; Dietel M; Possinger K
    Anticancer Res; 2004; 24(5B):3233-7. PubMed ID: 15510616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased serum levels of soluble CD44 standard, but not of variant isoforms v5 and v6, in B cell chronic lymphocytic leukemia.
    De Rossi G; Marroni P; Paganuzzi M; Mauro FR; Tenca C; Zarcone D; Velardi A; Molica S; Grossi CE
    Leukemia; 1997 Jan; 11(1):134-41. PubMed ID: 9001429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma.
    Salven P; Teerenhovi L; Joensuu H
    Blood; 1999 Nov; 94(10):3334-9. PubMed ID: 10552942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis.
    Ristamäki R; Joensuu H; Söderström KO; Jalkanen S
    J Pathol; 1995 Jul; 176(3):259-67. PubMed ID: 7545748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up.
    Virtamo J; Pietinen P; Huttunen JK; Korhonen P; Malila N; Virtanen MJ; Albanes D; Taylor PR; Albert P;
    JAMA; 2003 Jul; 290(4):476-85. PubMed ID: 12876090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicobacter pylori infection and gastric lymphoma.
    Parsonnet J; Hansen S; Rodriguez L; Gelb AB; Warnke RA; Jellum E; Orentreich N; Vogelman JH; Friedman GD
    N Engl J Med; 1994 May; 330(18):1267-71. PubMed ID: 8145781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of tumor markers CA 125 and CA 15.3 at diagnosis and during follow-up in non-Hodgkin's lymphoma: study of 200 patients.
    Batlle M; Ribera JM; Oriol A; Pastor C; Mate JL; Fernández-Avilés F; Flores A; Millá F; Feliu E
    Leuk Lymphoma; 2005 Oct; 46(10):1471-6. PubMed ID: 16194893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of elevated serum CD44 levels in patients with oral squamous cell carcinoma.
    Sawant S; Ahire C; Dongre H; Joshi S; Jamghare S; Rane P; Kane S; Chaukar D
    J Oral Pathol Med; 2018 Aug; 47(7):665-673. PubMed ID: 29752852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma.
    Guney N; Soydinc HO; Basaran M; Bavbek S; Derin D; Camlica H; Yasasever V; Topuz E
    Asian Pac J Cancer Prev; 2009; 10(4):669-74. PubMed ID: 19827892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma].
    Pérez Encinas M; Bello JL; Bendaña A; Rabuñal MJ; González S; Abuín I; Noya M; Cadarso C
    Med Clin (Barc); 1998 Jul; 111(5):161-7. PubMed ID: 9732831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma.
    Schroeder JR; Saah AJ; Hoover DR; Margolick JB; Ambinder RF; Martinez-Maza O; Breen EC; Jacobson LP; Variakojis D; Rowe DT; Armenian HK
    Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):979-84. PubMed ID: 10566552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum CD44 in malignant lymphoma: an association with treatment response.
    Ristamäki R; Joensuu H; Salmi M; Jalkanen S
    Blood; 1994 Jul; 84(1):238-43. PubMed ID: 7517210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy.
    Bibas M; Trotta MP; Cozzi-Lepri A; Lorenzini P; Pinnetti C; Rizzardini G; Angarano G; Caramello P; Sighinolfi L; Mastroianni CM; Mazzarello G; Di Caro A; Di Giacomo C; d'Arminio Monforte A; Antinori A;
    Am J Hematol; 2012 Aug; 87(8):749-53. PubMed ID: 22718364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
    Lazzarino M; Orlandi E; Klersy C; Astori C; Brusamolino E; Corso A; Bellio L; Gargantini L; Morra E; Bernasconi C
    Cancer; 1998 Feb; 82(3):576-82. PubMed ID: 9452277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High serum interleukin-6 levels correlate with a shorter failure-free survival in indolent lymphoma.
    Fayad L; Cabanillas F; Talpaz M; McLaughlin P; Kurzrock R
    Leuk Lymphoma; 1998 Aug; 30(5-6):563-71. PubMed ID: 9711918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Origin and function of circulating CD44 in non-Hodgkin's lymphoma.
    Ristämaki R; Joensuu H; Grön-Virta K; Salmi M; Jalkanen S
    J Immunol; 1997 Mar; 158(6):3000-8. PubMed ID: 9058839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas.
    Terpe HJ; Koopmann R; Imhof BA; Günthert U
    J Pathol; 1994 Oct; 174(2):89-100. PubMed ID: 7525912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble Fas in the serum of patients with non-Hodgkin's lymphoma: higher concentrations in angioimmunoblastic T-cell lymphoma.
    Yufu Y; Choi I; Hirase N; Tokoro A; Noguchi Y; Goto T; Uike N; Kozuru M
    Am J Hematol; 1998 Aug; 58(4):334-6. PubMed ID: 9692400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of serum IL-2, IL-6 and IL-10 levels with International Prognostic Index in patients with aggressive non-Hodgkin's lymphoma.
    Aydin F; Yilmaz M; Ozdemir F; Kavgaci H; Yavuz MN; Yavuz AA
    Am J Clin Oncol; 2002 Dec; 25(6):570-2. PubMed ID: 12478000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential use of serum CD44 as an indicator of tumour progression in acute leukemia.
    Yokota A; Ishii G; Sugaya Y; Nishimura M; Saito Y; Harigaya K
    Hematol Oncol; 1999 Dec; 17(4):161-8. PubMed ID: 10725871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.